Market Overview

UPDATE: Wedbush Downgrades Illumina to Neutral on Risk/Reward

Share:
Related ILMN
12 Stocks Moving In Wednesday's Pre-Market Session
12 Stocks You Should Be Watching Today
Baron Funds Comments on Illumina (GuruFocus)

Wedbush reduced its rating on Illumina (NASDAQ: ILMN) from Outperform to Neutral and reiterated its $52 price target.

Wedbush noted, "We have spoken with several typical sequencing customers recently that are either putting off or second guessing HiSeq purchases because of the attractive price point of ILMN's own sequencing service. In addition, for the first time, we are hearing about instances of used HiSeq 2000's for sale on the secondary market at steep discounts. On a positive note, near-term project pipelines appear robust and, despite continued MiSeq teething pains, feedback remains largely positive to date, with plans for greater utilization by core labs in 2013."

Illumina closed at $55.55 on Thursday.

Latest Ratings for ILMN

DateFirmActionFromTo
May 2016CitigroupMaintainsBuy
May 2016Morgan StanleyMaintainsEqual-weight
May 2016NomuraMaintainsBuy

View More Analyst Ratings for ILMN
View the Latest Analyst Ratings

Posted-In: WedbushAnalyst Color Downgrades Intraday Update Analyst Ratings

 

Related Articles (ILMN)

View Comments and Join the Discussion!